We manufacture and supply Linagliptin as API (Active Pharmaceutical Ingredient). It is orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
ISO9001, GMP and FDA are available for your audits.
Product Attributes
Formal Name: 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
Synonyms: BI1356, Tradjenta, Trajenta
Molecular Formula: C25H28N8O2
Formula Weight: 472.5
Assay: 98.0% ~102.0%
Appearance: Off- white Crystalline Powder
Our Productions of Linagliptin API and Intermediates
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Package
Shipping
You can choose your own freight forwarder or we can send through TNT, DHL and other channels according to your needs.
http://www.sdsihuan.com/